Published in TB and Outbreaks Week, September 3rd, 2002
"Salicylate induces multiple antibiotic resistance in various bacterial species," according to Dr. Alain Schaller and colleagues working at Johns Hopkins University's Bloomberg School of Public Health in Baltimore.
Schaller and coauthors showed that salicylate-based drugs reduce M. tuberculosis susceptibility to a number of anti-TB medications.
The researchers used tetrazolium redox dye viability and bacterial survival assays to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.